Impact of Haemophilus influenzae type b conjugate vaccine on bacterial meningitis in the Dominican Republic

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 24, Issue 3, 2008, Pages 161-168

  Lee, Ellen H ^a,b,c   Corcino, Miriam ^d   Moore, Arelis ^d   Garib, Zacarias ^d   Peña, Chabela ^e   Sánchez, Jacqueline ^e   Fernández, Josefina ^e   Feris Iglesias, Jesús M ^e   Flannery, Brendan ^a  

^a National Center for Immunizations and Respiratory Diseases

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Unit F   (United States)

^d Centro Nacional de Control de Enfermedades Tropicales   (Dominican Republic)

^e School of Medicine   (Dominican Republic)

Author keywords

Bacterial meningitis; Dominican Republic; Haemophilus influenzae type b conjugate vaccine; Immunization

Indexed keywords

BACTERIAL DISEASE; CHILD HEALTH; DISEASE CONTROL; ETIOLOGY; HOSPITAL SECTOR; MENINGITIS; VACCINATION; VACCINE;

ATLANTIC ISLANDS; ATLANTIC OCEAN; CARIBBEAN ISLANDS; DOMINICAN REPUBLIC; GREATER ANTILLES;

BACTERIA (MICROORGANISMS); HAEMOPHILUS INFLUENZAE SEROTYPE B;

EID: 54549095997     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892008000900002     Document Type: Article

References (26)

1. Danovaro-Holliday MC, Garcia S, de Quadros C, Tambini G, Andrus JK. Progress in vaccination against Haemophilus influenzae type b in the Americas. PLoS Medicine. 2008;5(4):530-6.
2. Peltola H. Haemophilus influenzae type b disease and vaccination in Latin America and the Caribbean. Pediatr Infect Dis J. 1997;16(8):780-7.
3. Bennett J, Platonov A, Slack M, Mala P, Burton A, Robertson S. Haemophilus influenzae type b (Hib) meningitis in the pre-vaccine era: a global review of incidence, age distributions, and case-fatality rates. Geneva: WHO; 2002.
4. Landaverde M, Di Fabio JL, Ruocco G, Leal I, de Quadros C. Introducción de la vacuna conjugada contra Hib en Chile y Uruguay. Rev Panam Salud Publica. 1999;5(3):200-6.
5. Ribeiro GS, Reis JN, Cordeiro SM, Lima JB, Gouveia EL, Petersen M, et al. Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil. J Infect Dis. 2003;187(1):109-16.
6. Wenger JD, Di Fabio J, Landaverde JM, Levine OS, Gaafar T. Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four 'newly adopting' countries. Vaccine. 1999;18(7-8):736-42.
7. Martin M, Casellas JM, Madhi SA, Urquhart TJ, Delport SD, Ferrero F, et al. Impact of Haemophilus influenzae type b conjugate vaccine in South Africa and Argentina. Pediatr Infect Dis J. 2004;23(9):842-7.
8. Muganga N, Uwimana J, Fidele N, Gahimbare L, Gessner BD, Mueller JE, et al. Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda. Vaccine. 2007;25(39-40):7001-5.
9. Alvis Guzman N, de la Hoz Restrepo F, Vivas Consuelo D. Relación costo-efectividad de la vacuna contra Haemophilus influenzas tipo b en niños menores de dos años de edad en Colombia. Rev Panam Salud Publica. 2006;20(4):248-55.
10. Secretaria de Estado de Salud Publica y Asistencia Social RD. Normas nacionales para la vigilancia epidemiologica de enfermedades transmisibles y otros eventos. In: Secretaria de Estado de Salud Publica y Asistencia Social SD, Distrito Nacional, editor; 1998.
11. Gomez, E, Peguero M, Sanchez J, Castellanos PL, Feris J, Pena C, et al. Population-based surveillance for bacterial meningitis in the Dominican Republic: implications for control by vaccination. Epidemiol Infect. 2000;125(3):549-54.
12. World Health Organization. Immunization profile-Dominican Republic. Geneva: WHO. Available from: http://www.who.int/vaccines/globalsummary/ immunization/countryprofileresult.cfm. Accessed 29 March 2008.
13. WHO Statistical Information System Core Health Indicators. Geneva: WHO. Available from: http://www.who.int/whosis/database/core/core_select.cfm. Accessed 29 March 2008.
14. GAVI Alliance. Eligible countries. Geneva: GAVI Alliance. Available from: http://www.gavialliance.org/support/who/eligible/ index.php. Accessed 29 March 2008.
15. Japan International Cooperation Agency. Latin America: List of JIC A projects in Central America. Tokyo: JICA. Available from: http://www.jica.go.jp/ usa/activities/list.html. Accessed 29 March 2008.
16. Cowgill KD, Ndiritu M, Nyiro J, Slack MP, Chiphatsi S, Ismail A, et al. Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA. 2006;296(6):671-8.
17. Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ. 1985;63(6):1055-68.
18. Andrade AL, Martelli CM. Globalisation of Hib vaccination-how far are we? Lancet. 2005;365(9453):5-7.
19. Lagos R, Horwitz I, Toro J, San Martin O, Abrego P, Bustamante C, et al. Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzas type b infections. Pediatr Infect Dis J. 1996;15(3):216-22.
20. Lee EH, Lewis RF, Makumbi I, Kekitiinwa A, Ediamu TD, Bazibu M, et al. Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study. Trop Med Int Health. 2008;13(4):495-502.
21. Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, Usen S, et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet. 2005;366(9480):144-50.
22. Obonyo CO, Lau J. Efficacy of Haemophilus influenzae type b vaccination of children: a meta-analysis. Eur J Clin Microbiol Infect Dis. 2006;25(2):90-7.
23. Daza P, Banda R, Misoya K, Katsulukuta A, Gessner BD, Katsande R, et al. The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immu nodeficiency virus prevalence. Vaccine. 2006;24(37-39):6232-9.
24. Grimwood K, Anderson P, Anderson V, Tan L, Nolan T. Twelve year outcomes following bacterial meningitis: further evidence for persisting effects. Arch Dis Child. 2000;83(2):111-6.
25. Andrade AL, de Andrade JG, Martelli CM, e Silva SA, de Oliveira RM, Costa MS, et al. Ef fectiveness of Haemophilus influenzae b conjugate vaccine on childhood pneumonia: a casecontrol study in Brazil. Int J Epidemiol. 2004;33(1):173-81.
26. de la Hoz, F, Higuera AB, Di Fabio JL, Luna M, Naranjo AG, de la Luz Valencia M, et al. Effectiveness of Haemphilus influenzae type b vaccination against bacterial pneumonia in Colombia. Vaccine. 2004;23(1):36-42.